The Community Guide

- gsearch

Search Results

Narrow Results:

2019 3
2018 1
2017 1

United States 2

Journal Article 5

1 - 5 of 5 Results

Refine Results

Refine Results:

Current and new rotavirus vaccines

CITE Title : Current and new rotavirus vaccines Personal Author(s) : Burke, Rachel M.;Tate, Jacqueline E.;Kirkwood, Carl D.;Steele, A. Duncan;Parashar, Umesh D.; Published Date : October 2019;10-2019; Source : Curr Opin Infect Dis. 2019; 32(5):435-444 URL : https://stacks.cdc.gov/view/cdc/90843 Burke, Rachel M. et al. (2019). Current and new rotavirus vaccines. 32(5). Burke, Rachel M. et al. "Current and new rotavirus vaccines" 32, no. 5 (2019) Burke, Rachel M. et al. "Current and new rotavirus vaccines" vol. 32, no. 5, 2019 Export RIS Citation Information.

:

Burke, Rachel M. ;

Tate, Jacqueline E.

October 2019 | Curr Opin Infect Dis. 2019; 32(5):435-444

:

Recent findingsData generated from use of currently available products supports their effectiveness and impact in diverse settings. Rotavirus vaccines...
Evaluating Promising Investigational Medical Countermeasures: Recommendations in the Absence of Guidelines

CITE Title : Evaluating Promising Investigational Medical Countermeasures: Recommendations in the Absence of Guidelines Personal Author(s) : Bhadelia, Nahid;Sauer, Lauren;Cieslak, Theodore J.;Davey, Richard T.;McLellan, Susan;Uyeki, Timothy M.;Kortepeter, Mark G.; Published Date : 2019 Jan/Feb Source : Health Secur. 17(1):46-53 URL : https://stacks.cdc.gov/view/cdc/79951 Bhadelia, Nahid et al. (2019). Evaluating Promising Investigational Medical Countermeasures: Recommendations in the Absence of Guidelines. 17(1). Bhadelia, Nahid et al. "Evaluating Promising Investigational Medical Countermeasures: Recommendations in the Absence of Guidelines" 17, no. 1 (2019) Bhadelia, Nahid et al. "Evaluating Promising Investigational Medical Countermeasures: Recommendations in the Absence of Guidelines" vol. 17, no. 1, 2019 Export RIS Citation Information.

:

Bhadelia, Nahid ;

Sauer, Lauren

2019 Jan/Feb | Health Secur. 17(1):46-53

:

Emerging and re-emerging infectious diseases pose growing global public health threats. However, research on and development of medical countermeasure...
The development and approval of tecoviromat (TPOXX®), the first antiviral against smallpox

CITE Title : The development and approval of tecoviromat (TPOXX®), the first antiviral against smallpox Personal Author(s) : Merchlinsky, Michael;Albright, Andrew;Olson, Victoria;Schiltz, Helen;Merkeley, Tyler;Hughes, Claiborne;Petersen, Brett;Challberg, Mark; Published Date : June 07 2019 Source : Antiviral Res. 168:168-174 URL : https://stacks.cdc.gov/view/cdc/80233 Merchlinsky, Michael et al. (2019). The development and approval of tecoviromat (TPOXX®), the first antiviral against smallpox. 168 Merchlinsky, Michael et al. "The development and approval of tecoviromat (TPOXX®), the first antiviral against smallpox" 168 (2019) Merchlinsky, Michael et al. "The development and approval of tecoviromat (TPOXX®), the first antiviral against smallpox" vol. 168, 2019 Export RIS Citation Information.

:

Merchlinsky, Michael ;

Albright, Andrew

June 07 2019 | Antiviral Res. 168:168-174

:

The classification of smallpox by the U.S. Centers for Disease Control and Prevention (CDC) as a Category A Bioterrorism threat agent has resulted in ...
Ebola virus disease: an update on post-exposure prophylaxis

CITE Title : Ebola virus disease: an update on post-exposure prophylaxis Personal Author(s) : Fischer, William A;Vetter, Pauline;Bausch, Daniel G;Burgess, Timothy;Davey, Richard T;Fowler, Robert;Hayden, Frederick G;Jahrling, Peter B;Kalil, Andre C;Mayers, Douglas L;Mehta, Aneesh K;Uyeki, Timothy M;Jacobs, Michael; Published Date : November 15 2017 Source : Lancet Infect Dis. 18(6):e183-e192 URL : https://stacks.cdc.gov/view/cdc/79947 Fischer, William A et al. (2017). Ebola virus disease: an update on post-exposure prophylaxis. 18(6). Fischer, William A et al. "Ebola virus disease: an update on post-exposure prophylaxis" 18, no. 6 (2017) Fischer, William A et al. "Ebola virus disease: an update on post-exposure prophylaxis" vol. 18, no. 6, 2017 Export RIS Citation Information.

:

Fischer, William A ;

Vetter, Pauline

November 15 2017 | Lancet Infect Dis. 18(6):e183-e192

:

The massive outbreak of Ebola virus disease in west Africa between 2013 and 2016 resulted in intense efforts to evaluate the efficacy of several speci...
FDA Public Meeting Report on “Drug Interactions With Hormonal Contraceptives: Public Health and Drug Development Implications”

CITE Title : FDA Public Meeting Report on “Drug Interactions With Hormonal Contraceptives: Public Health and Drug Development Implications” Personal Author(s) : Akbar, Mohammad;Berry-Bibee, Erin;Blithe, Diana L.;Day, Ruth S.;Edelman, Alison;Höchel, Joachim;Jamshidi, Roxanne;Kim, Myong-Jin;Li, Li;Purohit, Vivek S.;Turpin, Jim A.;Scott, Pamela E.;Strauss, David G.;Sun, Haiying;Tepper, Naomi K.;Zhang, Lei;Yu, Chongwoo; Published Date : 12 2018 Source : J Clin Pharmacol. 58(12):1655-1665 URL : https://stacks.cdc.gov/view/cdc/154533 Akbar, Mohammad et al. (2018). FDA Public Meeting Report on “Drug Interactions With Hormonal Contraceptives: Public Health and Drug Development Implications”. 58(12). Akbar, Mohammad et al. "FDA Public Meeting Report on “Drug Interactions With Hormonal Contraceptives: Public Health and Drug Development Implications”" 58, no. 12 (2018) Akbar, Mohammad et al. "FDA Public Meeting Report on “Drug Interactions With Hormonal Contraceptives: Public Health and Drug Development Implications”" vol. 58, no. 12, 2018 Export RIS Citation Information.

:

Akbar, Mohammad ;

Berry-Bibee, Erin

12 2018 | J Clin Pharmacol. 58(12):1655-1665

:

Potential drug interactions with hormonal contraceptives are an important public health concern. A public meeting on "Drug Interactions With Hormonal ...